Run Dong

439 total citations · 1 hit paper
25 papers, 262 citations indexed

About

Run Dong is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Run Dong has authored 25 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Run Dong's work include Sepsis Diagnosis and Treatment (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Cardiac Arrest and Resuscitation (4 papers). Run Dong is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Cardiac Arrest and Resuscitation (4 papers). Run Dong collaborates with scholars based in China, Sweden and United Kingdom. Run Dong's co-authors include Huaping Dai, Huijuan Xiao, Dingyuan Jiang, Bin Du, Jinmin Peng, Li Weng, Xiao Hu, Chunyao Wang, Jing Geng and Xiaoxi Huang and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Run Dong

21 papers receiving 260 citations

Hit Papers

National incidence and mortality of hospitalized sepsis i... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Run Dong China 9 105 91 46 44 32 25 262
Qingtao Zhou China 9 111 1.1× 72 0.8× 50 1.1× 56 1.3× 87 2.7× 36 324
William Tillis United States 6 71 0.7× 92 1.0× 34 0.7× 39 0.9× 30 0.9× 10 264
Dimitra Gialamprinou Greece 9 53 0.5× 109 1.2× 100 2.2× 92 2.1× 82 2.6× 26 370
Ciro Canetta Italy 9 63 0.6× 55 0.6× 50 1.1× 61 1.4× 44 1.4× 33 410
Elena Arellano Spain 9 55 0.5× 45 0.5× 27 0.6× 63 1.4× 25 0.8× 20 214
Xiaochun Ma China 9 48 0.5× 103 1.1× 35 0.8× 63 1.4× 10 0.3× 28 304
G. Kris Bysani United States 8 80 0.8× 73 0.8× 63 1.4× 52 1.2× 22 0.7× 10 300
Peter Vervaart Australia 7 172 1.6× 71 0.8× 48 1.0× 51 1.2× 53 1.7× 9 451
Xianyao Wan China 8 61 0.6× 51 0.6× 27 0.6× 53 1.2× 20 0.6× 34 195
Chien‐Chou Hsiao Taiwan 12 135 1.3× 54 0.6× 75 1.6× 35 0.8× 15 0.5× 32 332

Countries citing papers authored by Run Dong

Since Specialization
Citations

This map shows the geographic impact of Run Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Dong more than expected).

Fields of papers citing papers by Run Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Dong. The network helps show where Run Dong may publish in the future.

Co-authorship network of co-authors of Run Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Run Dong. A scholar is included among the top collaborators of Run Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Run Dong. Run Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Run, et al.. (2025). Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities. Cell Death and Disease. 16(1). 878–878. 1 indexed citations
2.
Dong, Run & Yang Jiao. (2025). Chronic arsenic poisoning. QJM. 118(8). 593–594.
3.
Dong, Run, Huadong Zhu, Yun Long, et al.. (2025). Association Between Mechanical Power During Prone Positioning and Mortality in Patients With Acute Respiratory Distress Syndrome. Critical Care Medicine. 53(11). e2144–e2155.
4.
Li, Yuanyuan, Shan Li, Run Dong, et al.. (2024). Identifying optimal serum 1,3-β-D-Glucan cut-off for diagnosing Pneumocystis Jirovecii Pneumonia in non-HIV patients in the intensive care unit. BMC Infectious Diseases. 24(1). 1015–1015. 2 indexed citations
6.
7.
Liu, Yiwei, Yifan Wang, Run Dong, et al.. (2024). A nationwide study on new onset atrial fibrillation risk factors and its association with hospital mortality in sepsis patients. Scientific Reports. 14(1). 12206–12206. 3 indexed citations
8.
Li, Yuanyuan, Shan Li, Ran An, et al.. (2024). Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections. Infectious Diseases and Therapy. 13(4). 861–874. 1 indexed citations
9.
Wang, Jingyi, Yan Chen, Run Dong, et al.. (2024). Extracorporeal vs. conventional CPR for out-of-hospital cardiac arrest: A systematic review and meta-analysis. The American Journal of Emergency Medicine. 80. 185–193. 3 indexed citations
10.
Xu, Yang, Yifan Wang, Yiwei Liu, et al.. (2024). The Impact of Delayed Transition From Noninvasive to Invasive Mechanical Ventilation on Hospital Mortality in Immunocompromised Patients With Sepsis*. Critical Care Medicine. 52(11). 1739–1749. 3 indexed citations
11.
Dong, Run, Wei Liu, Li Weng, et al.. (2023). Temporal trends of sepsis-related mortality in China, 2006–2020: a population-based study. Annals of Intensive Care. 13(1). 71–71. 9 indexed citations
12.
Dong, Run, Jinmin Peng, Yan Chen, et al.. (2023). Validation of an ICD-Based Algorithm to Identify Sepsis: A Retrospective Study. Risk Management and Healthcare Policy. Volume 16. 2249–2257. 2 indexed citations
13.
Weng, Li, Yang Xu, Peng Yin, et al.. (2023). National incidence and mortality of hospitalized sepsis in China. Critical Care. 27(1). 84–84. 81 indexed citations breakdown →
14.
Dong, Run, Li Jiang, Ting Yang, et al.. (2022). Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial. Antimicrobial Agents and Chemotherapy. 66(3). e0204521–e0204521. 8 indexed citations
15.
Jiang, Dingyuan, Huijuan Xiao, Run Dong, et al.. (2022). Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis. The Clinical Respiratory Journal. 16(3). 234–243. 15 indexed citations
16.
Huang, Di, et al.. (2021). An Optimal Transit Fare and Frequency Design Model with Equity Impact Constraints. Journal of Transportation Engineering Part A Systems. 147(12).
17.
Dong, Run, Jianfang Zhou, Li Weng, et al.. (2020). External validity of Adult Sepsis Event’s simplified eSOFA criteria: a retrospective analysis of patients with confirmed infection in China. Annals of Intensive Care. 10(1). 14–14. 15 indexed citations
18.
Dong, Run, Min Liu, Xiaoxi Huang, et al.. (2020). <p>Water-Soluble C<sub><sup>60</sup></sub> Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice</p>. International Journal of Nanomedicine. Volume 15. 2269–2276. 10 indexed citations
20.
Hong, Xiafei, et al.. (2012). Acute Clenbuterol Induces Hypotension, Atrioventricular Block and Cardiac Asystole in the Rabbit. Cardiovascular Toxicology. 13(1). 85–90. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026